A synthetic peptide named P60 could bind to Foxp3, restrict its nuclear translocation, and reverse the biological activity for HCC (23), which indicated that Foxp3 was required to enter the nucleus to display its function. The gene discussed is FOXP3; the disease is hepatocellular carcinoma.